title: Low-dose Ara-C in the treatment of myelodysplastic syndromes.
authors.affiliation: Department of Medicine, Clinical Hospital Center-Rebro, Zagreb, Yugoslavia.
authors.forename: V
authors.initials: V
authors.lastname: Bogdanić
authors.forename: B
authors.initials: B
authors.lastname: Labar
authors.forename: M
authors.initials: M
authors.lastname: Mrsić
authors.forename: D
authors.initials: D
authors.lastname: Nemet
authors.forename: R
authors.initials: R
authors.lastname: Serventi-Seiwerth
mesh_terms: D003561:Cytarabine / Q000008:administration & dosage*; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic
chemical_list: D003561:Cytarabine